One in five patients with rheumatoid arthritis were undiagnosed during the pandemic

Written by | 6 Nov 2022

The number of new diagnoses of rheumatoid arthritis fell by 20% in the first year of the COVID-19 pandemic, new research suggests. The study, published today in The Lancet […]

Findings support repurposing rheumatoid arthritis drug auranofin for diabetes

Written by | 20 Oct 2022

Researchers at Baylor College of Medicine and collaborating institutions discovered that the rheumatoid arthritis drug auranofin can potentially be repurposed to improve diabetes-associated symptoms. The study, which was […]

Older adults with rheumatoid arthritis still undermedicated, despite aggressive guidelines

Written by | 27 May 2022

Despite guidelines that call for early and aggressive treatment of rheumatoid arthritis, a new study suggests many older adults are not prescribed disease-modifying medications for their inflammatory autoimmune […]

Rheumatoid arthritis drug cuts mortality among COVID-19 ventilated patients

Written by | 19 Feb 2022

Critically ill COVID-19 patients already on mechanical ventilation or extracorporeal membrane oxygenation have achieved a significantly higher rate of survival when randomized to receive baricitinib, a treatment for […]

New EULAR consensus on prevention trials in people at risk of developing RA

Written by | 27 Oct 2021

RA is an inflammatory autoimmune disease that causes pain, swelling and stiffness in the joints. It can also cause fatigue, and the underlying inflammation may affect other body […]

Parental smoking may increase children’s risk of developing rheumatoid arthritis

Written by | 16 Oct 2021

New research published in Arthritis & Rheumatology links parental smoking with an elevated risk of rheumatoid arthritis in children when they reach adulthood. Among 90,923 participants in the Nurses’ Health […]

Comorbidities and RA – study methodology

Written by | 9 Jan 2021

A recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) used distance matrices to match RA cases to controls with similar medical histories. The […]

Implications of findings in comorbidities of RA

Written by | 8 Jan 2021

The findings of a recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) could have important implications for practice, according to lead researcher Dr […]

Comorbidities and RA – study findings

Written by | 7 Jan 2021

A recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) produced a number of interesting findings, Dr Mark Tatangelo, the lead researcher explains. This study […]

Investigating comorbidities and rheumatoid arthritis

Written by | 6 Jan 2021

Rheumatoid arthritis (RA) affects about one percent of the population in the UK and comorbidities are reported to be common. A recent study from Canada was designed to […]

Sedentary Behaviour and RA

Written by | 16 Oct 2020

A study by O’Leary and colleagues, which appears in Arthritis Care & Research, looks at sedentary behaviour in people with RA and factors that may be associated with it. […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.